Skip to the page

Data / Form D filings / ValCor Cath Inc.

ValCor Cath Inc.: Form D filings

ValCor Cath Inc., a biotechnology company in Ottawa Hills, OH, filed 2 Form D notices with the SEC between 2023 and 2025. The latest, on August 14, 2025, reports $4.3 million sold of a $4.3 million offering to 52 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4146 HALIFAX ROAD, Ottawa Hills, OH, 43606
Phone
(631) 921-6820
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1979820

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 14, 2025Amendment$4,250,000$4,250,00052May 19, 2023sec.gov
Jun 8, 2023New notice$2,250,000$1,074,981$1,175,01911May 19, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Howard Kasi BobrowExecutive Officer
Michael BunkerDirector
P. Kasi RamanathanExecutive Officer, Director
Gary Kasi SmithDirector
Matthew Kasi PollmanDirector
Eugene JungExecutive Officer, Director

Other biotechnology companies in Ohio that filed recently

Every Form D from the week of Aug 11, 2025 · All recent filings in Ohio · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ValCor Cath Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.